These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 18792693

  • 1. Inhibitors targeting two-component signal transduction.
    Watanabe T, Okada A, Gotoh Y, Utsumi R.
    Adv Exp Med Biol; 2008; 631():229-36. PubMed ID: 18792693
    [Abstract] [Full Text] [Related]

  • 2. Tearing down the wall: peptidoglycan metabolism and the WalK/WalR (YycG/YycF) essential two-component system.
    Dubrac S, Msadek T.
    Adv Exp Med Biol; 2008; 631():214-28. PubMed ID: 18792692
    [Abstract] [Full Text] [Related]

  • 3. Two-component signal transduction as potential drug targets in pathogenic bacteria.
    Gotoh Y, Eguchi Y, Watanabe T, Okamoto S, Doi A, Utsumi R.
    Curr Opin Microbiol; 2010 Apr; 13(2):232-9. PubMed ID: 20138000
    [Abstract] [Full Text] [Related]

  • 4. Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections.
    Qin Z, Zhang J, Xu B, Chen L, Wu Y, Yang X, Shen X, Molin S, Danchin A, Jiang H, Qu D.
    BMC Microbiol; 2006 Nov 10; 6():96. PubMed ID: 17094812
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protein kinases as antibacterial targets.
    Schreiber M, Res I, Matter A.
    Curr Opin Cell Biol; 2009 Apr 10; 21(2):325-30. PubMed ID: 19246185
    [Abstract] [Full Text] [Related]

  • 7. [Two-component signal transduction as attractive drug targets in pathogenic bacteria].
    Utsumi R, Igarashi M.
    Yakugaku Zasshi; 2012 Apr 10; 132(1):51-8. PubMed ID: 22214580
    [Abstract] [Full Text] [Related]

  • 8. YycH regulates the activity of the essential YycFG two-component system in Bacillus subtilis.
    Szurmant H, Nelson K, Kim EJ, Perego M, Hoch JA.
    J Bacteriol; 2005 Aug 10; 187(15):5419-26. PubMed ID: 16030236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis.
    Yamamoto K, Kitayama T, Minagawa S, Watanabe T, Sawada S, Okamoto T, Utsumi R.
    Biosci Biotechnol Biochem; 2001 Oct 10; 65(10):2306-10. PubMed ID: 11758928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitors of bacterial two-component signalling systems.
    Macielag MJ, Goldschmidt R.
    Expert Opin Investig Drugs; 2000 Oct 10; 9(10):2351-69. PubMed ID: 11060812
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microbiology. Desperately seeking new antibiotics.
    Payne DJ.
    Science; 2008 Sep 19; 321(5896):1644-5. PubMed ID: 18801989
    [No Abstract] [Full Text] [Related]

  • 17. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus.
    Watanabe T, Hashimoto Y, Yamamoto K, Hirao K, Ishihama A, Hino M, Utsumi R.
    J Antibiot (Tokyo); 2003 Dec 19; 56(12):1045-52. PubMed ID: 15015732
    [Abstract] [Full Text] [Related]

  • 18. Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrity.
    Fernandez-Ciruelos B, Albanese M, Adhav A, Solomin V, Ritchie-Martinez A, Taverne F, Velikova N, Jirgensons A, Marina A, Finn PW, Wells JM.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0014624. PubMed ID: 38917423
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.